Tokyo, Japan

Takahiro Ochiya

This inventor holds 46 USPTO granted patents and 39 published patent applications, plus 2 CIPO patents and 18 EPO patents, primarily in Cancer Detection. Top assignees: National Cancer Center, Toray Industries, Inc., Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Ochiya. Retrieved from https://idiyas.com/inventor/takahiro-ochiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 46 

% Patents Active = 80.4

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 48(Granted Patents)


Location History:

  • Chou-ku, Tokyo, JP (2010)
  • Tokyo-to, JP (2014)
  • Tokyo, JP (2000 - 2024)

Company Filing History:

goldMedal30 out of 263 
 
National Cancer Center
 patents
silverMedal18 out of 3,581 
 
Toray Industries, Inc.
 patents
bronzeMedal5 out of 140 
 
Dainippon Sumitomo Pharma Co., Ltd.
 patents
4. 5 out of 54 
 
Koken Company, Limited
 patents
5. 5 out of 5 
 
Theoria Science Inc.
 patents
6. 3 out of 41 
 
3-D Matrix, Ltd.
 patents
7. 2 out of 200 
 
Daiichi Pharmaceutical Co., Ltd.
 patents
8. 2 out of 3 
 
Ds Pharma Biomedical Co., Ltd.
 patents
9. 1 out of 84 
 
Asahi Kasei Pharma Corporation
 patents
10. 1 out of 2 
 
Asahi Pharma Corporation
 patents
11. 1 out of 1 
 
Cynity Co., Ltd.
 patent
12. 1 out of 11 
 
Gene Techno Science Co., Ltd.
 patents
13. 1 out of 23 
 
Kewpie Corporation
 patents
14. 1 out of 1,040 
 
Shiseido Company, Limited
 patents
15. 1 out of 223 
 
Sii Nanotechnology Inc.
 patents
16. 1 out of 6,961 
 
Sumitomo Chemical Company, Limited
 patents
17. 1 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents
18. 1 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
19. 3 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cancer Detection
Prostate Cancer
Lung Cancer
Breast Cancer
MicroRNA
Exosome Analysis
Ovarian Tumor
Bladder Cancer
Stem Cells
Therapeutic Agents
Nucleic Acid Transfer
Tumor Treatment
46 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Journey of Takahiro Ochiya

Introduction: Takahiro Ochiya, a prolific inventor based in Tokyo, Japan, has made significant contributions to the field of medical diagnostics with an impressive portfolio of 36 patents. His groundbreaking work in the detection of pancreatic and prostate cancers has revolutionized the way these diseases are diagnosed and monitored.

Latest Patents:

1. Method of examining the possibility of a subject having pancreatic cancer: Ochiya's innovation involves measuring GPRC5C present in an exosome in a specimen collected from the subject, providing a novel approach to identifying pancreatic cancer at an early stage.

2. Prostate cancer detection kit or device, and detection method: His invention includes a kit or device for detecting prostate cancer, comprising a nucleic acid capable of binding to a miRNA in a subject's sample, offering a precise method for prostate cancer detection.

Career Highlights: Ochiya has lent his expertise to renowned institutions such as the National Cancer Center and Toray Industries, Inc. His dedication to advancing medical technology has paved the way for improved diagnostic tools in the fight against cancer.

Collaborations: Throughout his career, Ochiya has collaborated with esteemed colleagues such as Satoko Kozono and Hiroko Sudo, collectively contributing to the development of innovative medical solutions.

Conclusion: Takahiro Ochiya's innovative spirit and commitment to progress have not only shaped the landscape of medical diagnostics but have also instilled hope in the fight against cancer. His pioneering work serves as a testament to the power of innovation in improving healthcare outcomes and saving lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…